ข้ามไปยังเนื้อหา

Oncology

Thrombocytopenia Management

Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia. (เปิดหน้าต่างใหม่)

Berthelot-Richer M, Boilard B, Morin A, Bolduc B, Beauregard P, Kotb R.

Source‎: Transfusion 2012;52(4):739-41.

Indexed‎: PubMed 22082044

DOI‎: 10.1111/j.1537-2995.2011.03382.x

https://www.ncbi.nlm.nih.gov/pubmed/22082044 (เปิดหน้าต่างใหม่)

Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma. (เปิดหน้าต่างใหม่)

Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG.

Source‎: Pathol Oncol Res 2011;17(1):141-3.

Indexed‎: PubMed 20628840

DOI‎: 10.1007/s12253-010-9276-4

https://www.ncbi.nlm.nih.gov/pubmed/20628840 (เปิดหน้าต่างใหม่)

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. (เปิดหน้าต่างใหม่)

Duic JP, Grewal J, McConie K, Staszewski H, Haas J, Kesari S.

Source‎: J Neurooncol 2012;106(2):427-9.

Indexed‎: PubMed 21833801

DOI‎: 10.1007/s11060-011-0675-5

https://www.ncbi.nlm.nih.gov/pubmed/21833801 (เปิดหน้าต่างใหม่)

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. (เปิดหน้าต่างใหม่)

Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Hu K, Woodard P, Yang AS, Kantarjian HM.

Source‎: Cancer 2014;120(12):1838-46.

Indexed‎: PubMed 24706489

DOI‎: 10.1002/cncr.28663

https://www.ncbi.nlm.nih.gov/pubmed/24706489 (เปิดหน้าต่างใหม่)

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine. (เปิดหน้าต่างใหม่)

Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, Yang AS, Franklin J.

Source‎: Leuk Lymphoma 2013;54(2):321-8.

Indexed‎: PubMed 22906162

DOI‎: 10.3109/10428194.2012.713477

https://www.ncbi.nlm.nih.gov/pubmed/22906162 (เปิดหน้าต่างใหม่)

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. (เปิดหน้าต่างใหม่)

Kantarjian H, Fenaux P, Sekeres MA, Becker PS, Boruchov A, Bowen D, Hellstrom-Lindberg E, Larson RA, Lyons RM, Muus P, Shammo J, Siegel R, Hu K, Franklin J, Berger DP.

Source‎: J Clin Oncol 2010;28(3):437-44.

Indexed‎: PubMed 20008626

DOI‎: 10.1200/JCO.2009.24.7999

https://www.ncbi.nlm.nih.gov/pubmed/20008626 (เปิดหน้าต่างใหม่)

Romiplostim for management of chemotherapy-induced thrombocytopenia. (เปิดหน้าต่างใหม่)

Parameswaran R, Lunning M, Mantha S, Devlin S, Hamilton A, Schwartz G, Soff G.

Source‎: Support Care Cancer 2014;22(5):1217-22.

Indexed‎: PubMed 24414994

DOI‎: 10.1007/s00520-013-2074-2

https://www.ncbi.nlm.nih.gov/pubmed/24414994 (เปิดหน้าต่างใหม่)

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial. (เปิดหน้าต่างใหม่)

Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A.

Source‎: Lancet Haematol 2015;2(10):e417-26.

Indexed‎: PubMed 26686043

https://www.ncbi.nlm.nih.gov/pubmed/26686043 (เปิดหน้าต่างใหม่)

Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia. (เปิดหน้าต่างใหม่)

Raut SS, Shah SA, Sharanangat VV, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Shukla SN.

Source‎: Indian J Hematol Blood Transfus 2015;31(4):413-5.

Indexed‎: PubMed 26306064

DOI‎: 10.1007/s12288-014-0491-0

https://www.ncbi.nlm.nih.gov/pubmed/26306064 (เปิดหน้าต่างใหม่)

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. (เปิดหน้าต่างใหม่)

Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK.

Source‎: Blood 2010;116(12):2127-33.

Indexed‎: PubMed 20530792

DOI‎: 10.1182/blood-2010-03-276691

https://www.ncbi.nlm.nih.gov/pubmed/20530792 (เปิดหน้าต่างใหม่)

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. (เปิดหน้าต่างใหม่)

Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, Tamari R, Mitsiades CS, Verma A, Steidl U.

Source‎: Blood 2012;120(2):386-94.

Indexed‎: PubMed 22627766

DOI‎: 10.1182/blood-2011-12-399667

https://www.ncbi.nlm.nih.gov/pubmed/22627766 (เปิดหน้าต่างใหม่)

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. (เปิดหน้าต่างใหม่)

Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D.

Source‎: Cancer 2011;117(5):992-1000.

Indexed‎: PubMed 20945323

DOI‎: 10.1002/cncr.25545

https://www.ncbi.nlm.nih.gov/pubmed/20945323 (เปิดหน้าต่างใหม่)

Romiplostim treatment of chemotherapy-induced thrombocytopenia. (เปิดหน้าต่างใหม่)

Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S

Source‎: J Clin Oncol 2019;37(31):2892-8.

Indexed‎: PubMed 31545663

DOI‎: 10.1200/JCO.18.01931

https://www.ncbi.nlm.nih.gov/pubmed/31545663 (เปิดหน้าต่างใหม่)

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. (เปิดหน้าต่างใหม่)

Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, Kabrna E, Geissler K, Jilma B.

Source‎: Blood 2000;95(9):2983-9.

Indexed‎: PubMed 10779449

https://www.ncbi.nlm.nih.gov/pubmed/10779449 (เปิดหน้าต่างใหม่)

Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation. (เปิดหน้าต่างใหม่)

Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Fukuda T.

Source‎: Biol Blood Marrow Transplant 2016;22(5):919-24.

Indexed‎: PubMed 26785333

DOI‎: 10.1016/j.bbmt.2016.01.018

https://www.ncbi.nlm.nih.gov/pubmed/26785333 (เปิดหน้าต่างใหม่)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (เปิดหน้าต่างใหม่)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Source‎: Ann Oncol 2005;16(1):139-45.

Indexed‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (เปิดหน้าต่างใหม่)